NCT05110339: Efficacy of Dexmedetomidine on Postoperative Analgesia

Summary

This prospective, randomized, double-blind study is designed to evaluate the postoperative analgesic efficacy of dexmedetomidine as an adjunct to ropivacaine in erector spinae block in patients undergoing radical mastectomy. The investigators hypothesis is that the administration of ropivacaine 0.5% associated with dexmedetomidine in the blockade via the plane in the erector spinae is less effective in controlling acute postoperative pain in radical mastectomy than the administration of ropivacaine 0.5% without dexmedetomidine.

Timeline

Start: 2019-11-01
Primary completion: 2021-09-30
Completion: 2021-09-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dexmedetomidine	Other / unclassified	0.3 ug/kg	—
Background	Ropivacaine	Other / unclassified	0.5 %	—

Indications

No indication recorded.